Astrazeneca Plc ADR (AZN)

$78.99 0.97 (1.24%)

16:00 EDT AZN Stock Quote Delayed 30 Minutes

7 Biotech Stocks That Could Breathe New Life Into Your Portfolio

By Josh Enomoto, InvestorPlace Contributor May 20, 2024

Fundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying prioritization. While the media focuses on attaining wealth, that doesn’t…

7 Blue-Chip Stocks to Protect Your Wealth as the Economy Slows

7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025

7 Stocks to Buy Before the Next ‘Great Reset’ Begins in 2024

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 5.59M

Day's Range $78.38 - $79.47

52-Week Range $60.47 - $79.47

Dividend & Yield $0.93 (1.18%)

AZN Stock Predictions, Articles, and Astrazeneca Plc ADR News

From InvestorPlace
From the Web

AZN Stock Earnings: AstraZeneca Misses EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings Apr 25, 2024

AZN stock results show that AstraZeneca missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge

By Faisal Humayun, InvestorPlace Contributor Apr 23, 2024

These are the undervalued pharmaceutical stocks to buy as they have a deep clinical pipeline which will driven earnings and cash flow growth.

3 Blue-Chip Stocks to Buy as High Inflation Persists

By Faisal Humayun, InvestorPlace Contributor Apr 19, 2024

These are the undervalued blue-chip stocks for inflation protection, with the Fed likely to delay the first interest rate cut.

3 Pharma Stocks That Are Money-Printing Machines in 2024

By Michael Que, InvestorPlace Contributor Apr 15, 2024

The economy, and pharma industry, are projected to grow massively. You should invest in these top three pharma stocks.

7 Blue-Chip Stocks That Will Outperform the Dow in the 5 Five Years

By Faisal Humayun, InvestorPlace Contributor Mar 28, 2024

These are the blue-chip stocks to outperform Dow in the next five years and represents companies with growth and cash flow visibility.

3 Stagnating Blue-Chip Stocks Ready to Awaken and Soar

By Faisal Humayun, InvestorPlace Contributor Mar 20, 2024

These are the stagnating blue-chip stocks to buy at undervalued levels, as they represent fundamentally strong ideas with healthy cash flows.

Why Is Fusion Pharmaceuticals (FUSN) Stock Up 101% Today?

By William White, InvestorPlace Writer Mar 19, 2024

Fusion Pharmaceuticals stock is rising higher on Tuesday as AstraZeneca agrees to acquire FUSN for $21 per share with a CVR of $3.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Mar 19, 2024

Pre-market stock movers are worth diving into on Tuesday as we check out all of the hottest news worth reading about this morning!

7 Mega-Cap Stocks That Can Turn $10,000 Into $1 Million

By Alex Sirois, InvestorPlace Contributor Mar 15, 2024

These million dollar mega cap stocks will continue to produce big winners in 2024 and beyond as they continue to rise.

3 Inflation-Resilient Stocks to Weather the Economic Turbulence

By Faisal Humayun, InvestorPlace Contributor Feb 28, 2024

These are the undervalued inflation-resilient stocks to buy as they represent companies that have strong fundamentals.

Move Over Magnificent 7, Say Hello to the GRANOLAS

By Matthew Farley, InvestorPlace Contributor Feb 22, 2024

Dive into the compelling world of GRANOLAS stocks: Europe's elite players shaping the future of pharmaceuticals, tech, and consumer goods.

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

By Josh Enomoto, InvestorPlace Contributor Feb 15, 2024

Last October, life sciences giant Thermo Fisher Scientific (NYSE:TMO) inadvertently laid out the case for contrarian biotech stocks. According to Reuters, the company revealed that…

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution

By Alex Sirois, InvestorPlace Contributor Feb 14, 2024

Obesity drug sales boomed in 2023 and will continue in 2024 making these weight loss stocks attratcive considerations for pharma investors.

3 Stocks at 52-Week Lows to Buy Before They Rebound

By Rich Duprey, InvestorPlace Contributor Feb 12, 2024

One of the secrets to generating fabulous wealth is by finding mispriced stocks at 52-week lows to buy and hold.

NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?

By Rich Duprey, InvestorPlace Contributor Feb 5, 2024

The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs.

7 Dividend-Paying Stocks To Add To Your Income Portfolio In 2024

By Faisal Humayun, InvestorPlace Contributor Jan 3, 2024

These are the undervalued and fundamentally strong dividend-paying stocks to buy for high total returns in the next 24 to 36 months.

Why Is Compugen (CGEN) Stock Up 189% Today?

By William White, InvestorPlace Writer Dec 19, 2023

Compugen stock is up on Tuesday as investors in CGEN shares react to an exclusive licensing agreement with Gilead Sciences.

Why Is Icosavax (ICVX) Stock Up 46% Today?

By William White, InvestorPlace Writer Dec 12, 2023

Icosavax stock is up on Tuesday as investors react to an acquisition deal with AstraZeneca that values ICVX between $15 and $20 per share.

5 Growth Stocks to Buy for 2024

By Thomas Yeung, CFA, InvestorPlace Markets Analyst Nov 20, 2023

Forget the "Magnificent 7." These are the top five growth stocks to buy in the coming year for interested investors.

The 7 Next Trillion Dollar Companies to Invest in to Become a Millionaire

By Faisal Humayun, InvestorPlace Contributor Nov 10, 2023

These are the next trillion-dollar companies to buy as they represent strong business fundamentals with robust cash flow upside potential.

Astrazeneca Plc ADR (AZN)

7 Biotech Stocks That Could Breathe New Life Into Your Portfolio

7 Blue-Chip Stocks to Protect Your Wealth as the Economy Slows

7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025

7 Stocks to Buy Before the Next ‘Great Reset’ Begins in 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Astrazeneca Plc ADR (AZN)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AZN Stock Predictions, Articles, and Astrazeneca Plc ADR News

Subscriber Sign in